Swedish Orphan Biovitrum
411,00 SEK
+1,23 %
Mindre end 1K følgere
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Værdiansættelse
Resultatopgørelse
Kvartalsdata
Kvartalsdata
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Swedish Orphan Biovitrum
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Omsætning | 6.894,0 | 7.435,0 | 26.027,0 | 6.465,0 | 6.175,0 | 7.776,0 | 7.822,0 | 28.238,0 |
| EBITDA | 2.962,0 | 2.638,0 | 9.304,0 | 2.296,0 | 1.899,0 | 3.656,0 | 3.112,0 | 10.963,0 |
| EBIT | 2.038,0 | 1.662,0 | 5.625,0 | 1.358,0 | 1.010,0 | -3.858,0 | 2.357,0 | 867,0 |
| EBIT-% | 29,6 % | 22,4 % | 21,6 % | 21,0 % | 16,4 % | -49,6 % | 30,1 % | 3,1 % |
| Overskud før skat | 1.712,0 | 1.438,0 | 4.407,0 | 1.096,0 | 794,0 | -4.027,0 | 2.171,0 | 34,0 |
| Netto indkomst | 1.464,0 | 1.391,0 | 3.879,0 | 875,0 | 634,0 | -2.895,0 | 1.862,0 | 476,0 |